Safety and Efficacy of Fospropofol vs Propofol During Invasive Mechanical Ventilation.
Not Applicable
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-02-15
- Last Posted Date
- 2024-02-15
- Lead Sponsor
- Henan Provincial People's Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT06261996
Application Value of Whole-procedure Optimization for Catheter Ablation of Atrial Fibrillation
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-11-24
- Last Posted Date
- 2024-03-18
- Lead Sponsor
- Henan Provincial People's Hospital
- Target Recruit Count
- 400
- Registration Number
- NCT06145906
- Locations
- π¨π³
Department of Cardiology, Henan Provincial People's Hospital, Zhengzhou, Henan, China
Effect of Esketamine on Reducing Postoperative Anxiety and Depression in Adolescent Patients
- First Posted Date
- 2023-10-10
- Last Posted Date
- 2023-10-10
- Lead Sponsor
- Henan Provincial People's Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT06073015
Preoperative Cognitive Impairment Predicts Postoperative Delirium
Completed
- Conditions
- Interventions
- First Posted Date
- 2023-04-05
- Last Posted Date
- 2023-04-05
- Lead Sponsor
- Henan Provincial People's Hospital
- Target Recruit Count
- 150
- Registration Number
- NCT05798767
- Locations
- π¨π³
Henan People's Hospital, Zhengzhou, China
Neoadjuvant Treatment of Fruquintinib Combined With Concurrent Chemoradiotherapy for LARC
Phase 2
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-10-12
- Last Posted Date
- 2022-10-12
- Lead Sponsor
- Henan Provincial People's Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT05575635
Radiogenomics in Glioblastoma: Correlation Between Multiparametric Imaging Biomarkers and Genetic Biomarkers
- First Posted Date
- 2022-09-15
- Last Posted Date
- 2022-09-27
- Lead Sponsor
- Henan Provincial People's Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT05541042
- Locations
- π¨π³
Henan Provincial People's Hospital, Zhengzhou, Henan, China
Tislelizumab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for Bevacizumab Refractory Recurrent Glioblastoma
Phase 2
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-09-14
- Last Posted Date
- 2023-10-06
- Lead Sponsor
- Henan Provincial People's Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT05540275
- Locations
- π¨π³
Henan Provincial People's Hospital, Zhengzhou, Henan, China
Personalized Trial in ctDNA-level-relapse Glioblastoma
Not Applicable
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-09-14
- Last Posted Date
- 2022-09-27
- Lead Sponsor
- Henan Provincial People's Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT05539339
- Locations
- π¨π³
Henan Provincial People's Hospital, Zhengzhou, Henan, China
Correlation Between Psychological Stress and Progression of Newly Oligodendroglioma Towards Secondary Glioma
- First Posted Date
- 2022-09-13
- Last Posted Date
- 2022-09-27
- Lead Sponsor
- Henan Provincial People's Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT05536986
Efficacy and Safety of Microwave Ablation Combined With Camrelizumab and Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer: a Multicenter, Open, Prospective Study
Not Applicable
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-09-08
- Last Posted Date
- 2022-09-08
- Lead Sponsor
- Henan Provincial People's Hospital
- Target Recruit Count
- 35
- Registration Number
- NCT05532527
Β© Copyright 2024. All Rights Reserved by MedPath